Citigroup
CCRN

Citigroup’s Cross Country Healthcare CCRN Stock Holding History

Citigroup’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8K Sell
1,473
-8,981
-86% -$80.4K ﹤0.01% 4926
2025
Q4 		$84.7K Sell
10,454
-1,164
-10% -$12.7K ﹤0.01% 4390
2025
Q3 		$165K Sell
11,618
-6,214
-35% -$82.1K ﹤0.01% 4071
2025
Q2 		$233K Sell
17,832
-12,905
-42% -$177K ﹤0.01% 4000
2025
Q1 		$458K Buy
30,737
+2,047
+7% +$35.2K ﹤0.01% 3728
2024
Q4 		$521K Sell
28,690
-14,194
-33% -$191K ﹤0.01% 3794
2024
Q3 		$576K Buy
42,884
+6,284
+17% +$92.6K ﹤0.01% 3637
2024
Q2 		$507K Buy
36,600
+5,523
+18% +$87.4K ﹤0.01% 3389
2024
Q1 		$582K Buy
31,077
+5,252
+20% +$105K ﹤0.01% 3464
2023
Q4 		$585K Buy
25,825
+9,974
+63% +$216K ﹤0.01% 3288
2023
Q3 		$393K Sell
15,851
-16,224
-51% -$408K ﹤0.01% 3243
2023
Q2 		$901K Buy
32,075
+14,420
+82% +$358K ﹤0.01% 2927
2023
Q1 		$394K Sell
17,655
-4,179
-19% -$109K ﹤0.01% 3290
2022
Q4 		$580K Buy
21,834
+4,377
+25% +$143K ﹤0.01% 3060
2022
Q3 		$495K Buy
17,457
+1,239
+8% +$31.9K ﹤0.01% 3241
2022
Q2 		$338K Sell
16,218
-15,350
-49% -$288K ﹤0.01% 3520
2022
Q1 		$684K Buy
31,568
+1,751
+6% +$38K ﹤0.01% 3288
2021
Q4 		$828K Buy
29,817
+9,634
+48% +$234K ﹤0.01% 3429
2021
Q3 		$429K Buy
20,183
+1,425
+8% +$26.7K ﹤0.01% 3710
2021
Q2 		$310K Sell
18,758
-31,164
-62% -$476K ﹤0.01% 3999
2021
Q1 		$624K Buy
49,922
+41,473
+491% +$440K ﹤0.01% 3307
2020
Q4 		$75K Buy
8,449
+6,309
+295% +$51.3K ﹤0.01% 5759
2020
Q3 		$14K Sell
2,140
-7,737
-78% -$49K ﹤0.01% 6402
2020
Q2 		$61K Sell
9,877
-1,049
-10% -$6.44K ﹤0.01% 5901
2020
Q1 		$74K Sell
10,926
-5,952
-35% -$56.4K ﹤0.01% 5615
2019
Q4 		$196K Sell
16,878
-5,880
-26% -$66.4K ﹤0.01% 5195
2019
Q3 		$235K Sell
22,758
-4,228
-16% -$41.6K ﹤0.01% 5027
2019
Q2 		$253K Buy
26,986
+5,913
+28% +$45.5K ﹤0.01% 5058
2019
Q1 		$149K Sell
21,073
-37,421
-64% -$321K ﹤0.01% 5376
2018
Q4 		$429K Buy
58,494
+34,456
+143% +$289K ﹤0.01% 4295
2018
Q3 		$210K Buy
24,038
+13,633
+131% +$139K ﹤0.01% 5203
2018
Q2 		$117K Sell
10,405
-3,398
-25% -$40.5K ﹤0.01% 5574
2018
Q1 		$153K Sell
13,803
-340
-2% -$4.26K ﹤0.01% 5219
2017
Q4 		$180K Sell
14,143
-16,928
-54% -$224K ﹤0.01% 5147
2017
Q3 		$442K Sell
31,071
-10,891
-26% -$136K ﹤0.01% 4242
2017
Q2 		$541K Buy
41,962
+12,253
+41% +$158K ﹤0.01% 3915
2017
Q1 		$427K Sell
29,709
-42,684
-59% -$628K ﹤0.01% 4007
2016
Q4 		$1.13M Buy
72,393
+41,856
+137% +$573K ﹤0.01% 3548
2016
Q3 		$359K Buy
30,537
+18,948
+163% +$249K ﹤0.01% 4195
2016
Q2 		$161K Sell
11,589
-12,330
-52% -$163K ﹤0.01% 4688
2016
Q1 		$278K Buy
23,919
+20,259
+554% +$257K ﹤0.01% 4768
2015
Q4 		$60K Buy
3,660
+96
+3% +$1.53K ﹤0.01% 5782
2015
Q3 		$49K Sell
3,564
-413
-10% -$5.61K ﹤0.01% 5441
2015
Q2 		$50K Sell
3,977
-298
-7% -$3.38K ﹤0.01% 5529
2015
Q1 		$50K Sell
4,275
-12,740
-75% -$146K ﹤0.01% 5536
2014
Q4 		$212K Buy
17,015
+9,254
+119% +$94.5K ﹤0.01% 4642
2014
Q3 		$73K Sell
7,761
-82,138
-91% -$630K ﹤0.01% 5019
2014
Q2 		$586K Buy
89,899
+79,447
+760% +$525K ﹤0.01% 3348
2014
Q1 		$84K Sell
10,452
-15,935
-60% -$157K ﹤0.01% 5136
2013
Q4 		$263K Buy
26,387
+14,148
+116% +$98.1K ﹤0.01% 4416
2013
Q3 		$74K Sell
12,239
-6,561
-35% -$37.6K ﹤0.01% 4961
2013
Q2 		$97K Buy
+18,800
New +$96.3K ﹤0.01% 4879

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Citigroup's CCRN Position: Q1 2026 in Review

Citigroup reduced its Cross Country Healthcare (CCRN) stake by 86% in Q1 2026, selling an estimated $80.4K and leaving 1,473 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4926.

Citigroup first reported a position in CCRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.13M in Q4 2016. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Citigroup held 1,473 shares of Cross Country Healthcare worth $13.8K as of Q1 2026.
  • Citigroup sold 8,981 Cross Country Healthcare shares in Q1 2026, an estimated $80.4K.
  • Cross Country Healthcare made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4926 holding.
  • Citigroup first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Cross Country Healthcare position peaked at $1.13M in Q4 2016.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.